• Bored With Your Fitbit? These Cancer Researchers Aren't

    Sep 19, 2017, 13:21 by Michael Croft
    WIRED |  Scientists are publishing more studies and enrolling more clinical trials using Fitbit devices than any other wearable fitness tracker out there.
    Full story
  • ERT Reduces eCOA Delivery Time for Vaccine Trials by 75%

    Sep 19, 2017, 08:52 by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Sep 19, 2017 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced a technology platform that provides fast, regulatory compliant, and cost-effective clinical outcome assessment (COA) data capture during vaccine clinical development
    Full story
  • Parker Institute For Cancer Immunotherapy And The Tesla Collaboration

    Sep 18, 2017, 14:35 by Michael Croft

    Clinical Informatics News Brief | Danny Wells, an informatic scientist at the Parker Institute for Cancer Immunotherapy, is featured on this podcast from Cambridge Healthtech Institute for the ImPACT Conference. Topics include scaling up personalized therapies, future clinical applications of neoantigens, and new frontiers in cancer immunotherapy.

    Full story
  • Cenduit to Discuss Advanced Solutions at Clinical Trial Supply Chain Europe

    Sep 18, 2017, 12:06 by Michael Croft
    DURHAM, UNITED STATES - Sep 18, 2017 -  WHAT:  Cenduit LLC, the largest interactive response technology (IRT) specialist in the world, will be attending the Clinical Trial Supply Chain Europe meeting, September 26 in Zurich, Switzerland
    Full story
  • Blind Patients To Test Bionic Eye Brain Implants

    Sep 18, 2017, 11:07 by Michael Croft
    MIT Technology Review |  Second Sight is launching a clinical trial for a prosthesis that could help more people who have lost their vision than a device already on the market.
    Full story
  • Cofactor Genomics announces $18M funding in an oversubscribed Series-A round to bring RNA to Precision Medicine

    Sep 18, 2017, 10:28 by Michael Croft
    SAN FRANCISCO, CA, UNITED STATES - Sep 18, 2017 - Cofactor Genomics announces $18M funding in an oversubscribed Series-A round to bring RNA to Precision MedicineSan Francisco, CA - September 18, 2017Cofactor Genomics, developer of a leading platform for RNA sequencing and expression analysis, today announced $18M in financing led by Menlo Ventures with major participation from existing investor Data Collective (DCVC) and new investor Ascension Ventures, and participation from existing and new investors iSelect, Y Combinator, Wilson Sonsini Goodrich & Rosati, and Stanford
    Full story
  • BioIQ Announces the Appointment of Sherman Sanchez as Senior Vice President, Sales and Business Development

    Sep 14, 2017, 13:30 by Michael Croft
    ATLANTA - Sep 14, 2017 - BioIQ, a technology platform driving the employer and health plan shift to value-based care, announced today that Sherman Sanchez has been named senior vice president of sales and business development
    Full story
  • Voice Interactions: A Channel To Better Health Outcomes

    Sep 14, 2017, 09:45 by Michael Croft

    Clinical Informatics News Contributed Commentary | More often than not, patients forget or lack the motivation to follow a care plan that requires frequent monitoring and documentation. For many diseases that can be self-managed, the tools that use traditional channels, such as web/mobile/text, fail to reach high adoption rates because using them is usually a complicated and cumbersome experience. In this context, voice, as a channel of communication, is positioned to be a game changer.

    Full story
  • Redox Inks Contract With Boston Hospital To Integrate Patient Data

    Sep 13, 2017, 15:45 by Michael Croft
    Xconomy |  Brigham and Women's Hospital in Boston announced today a multiyear agreement with Redox to use the startup's tools to connect the Brigham's electronic health records system with outside software applications.
    Full story
  • Kyowa Hakko Kirin Joins Certara’s Simcyp Consortium

    Sep 13, 2017, 09:19 by Michael Croft
    PRINCETON, NJ - Sep 13, 2017 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that Kyowa Hakko Kirin Co
    Full story
  • FDA Is Advancing The Goals Of The Orphan Drug Act

    Sep 12, 2017, 14:55 by Michael Croft

    FDA Voice | Scott Gottlieb, commissioner of the Food & Drug Administration gives an update on their progress in meeting the goals initially established for the FDA’s Orphan Drug Act (ODA).

    Full story
  • It’s About Time: Sites Need To Stop Reinventing The Wheel

    Sep 12, 2017, 08:30 by Michael Croft

    Clinical Informatics News | It’s About Time | Terry Stubbs, President & CEO of ActivMed Practices & Research, thinks it’s time that more sites need to take advantage of industry standards. “Sites of excellence understand that using internal and industry-standard procedures, training, forms, checklists, metrics, certifications, etc., not only save time, but also improve quality,” she says.

    Full story
  • ERT Introduces Express Overread Service for Respiratory Clinical Trials

    Sep 11, 2017, 13:49 by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Sep 11, 2017 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced the availability of its Express Overread service for clinical trials that require spirometry and pulmonary function testing (PFT)
    Full story
  • Suicide Data Incorrectly Reported In Drug Trials, Suit Claimed

    Sep 11, 2017, 12:39 by Michael Croft
    The New York Times |  Paxil was approved following large clinical trials. But two suicides recorded in the placebo group should not have been counted, an F.D.A. reviewer wrote.
    Full story
  • New Clinical Trial Might Change The Standard Treatment For Melanoma

    Sep 11, 2017, 11:15 by Michael Croft
    Washington Post |  A faceoff between two immunotherapy drugs showed a clear winner - and it wasn't the one most patients get.
    Full story
  • ArisGlobal Announces LifeSphere Mobile MA™, Life Science’s First Multi-Function, Self-Service Portal for Medical Affairs and Pharmacovigilance

    Sep 11, 2017, 10:20 by Michael Croft
    MIAMI, FL, UNITED STATES - Sep 13, 2017 - ArisGlobal, a leading provider of integrated, multi-tenant cloud-based software solutions for life sciences, today announced that LifeSphere Mobile MA™ is the first multi-lingual service portal and mobile app for medical affairs and pharmacovigilance to help sales reps, medical science liaisons (MSLs), healthcare professionals and even patients access approved product content, address adverse event management, and submit medical inquiries and product quality complaints from any mobile device
    Full story
  • ERT Acquires Biomedical Systems

    Sep 11, 2017, 10:17 by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Sep 8, 2017 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has acquired Biomedical Systems, a well-recognized provider of reliable imaging, as well as cardiac safety and respiratory data collection solutions
    Full story
  • Patients Without Traditional Cancer Screening Find Allies In Maccabi And Medial EarlySign

    Sep 8, 2017, 08:55 by Michael Croft

    Clinical Informatics News | Maccabi Healthcare System is using Medial EarlySign’s clinical decision support tool to find colon cancer patients among individuals who didn’t go through traditional channels for screening.

    Full story
  • BioIVT Acquires Qualyst Transporter Solutions, Enables Researchers to Predict New Drug Candidates’ Impact on the Liver

    Sep 7, 2017, 12:31 by Michael Croft
    WESTBURY, NY - Sep 7, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it has acquired Qualyst Transporter Solutions, LLC
    Full story
  • FDA’s Plan To Engage The Public

    Sep 7, 2017, 12:20 by Michael Croft
    FDA Voice |  Over the past few months, FDA has announced a number of broad policy efforts to address public health opportunities in areas such as regenerative medicine, tobacco products, and access to affordable medicines.
    Full story
  • «
  • 221
  • 222
  • 223
  • 224
  • 225
  • 226 (current)
  • 227
  • 228
  • 229
  • 230
  • »